Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Overlap syndrome of Miller-Fisher syndrome/Pharyngeal-Cervical-Brachial variant-Guillain Barre Syndrome with anti-ganglioside complex antibodies

Annals of Clinical Neurophysiology 2020³â 22±Ç 2È£ p.112 ~ 116
À̼®À±, ¿À¼ºÀÏ, Çã¼Ò¿µ, ½Å°æÁø, ±èÁ¾±¹, À±º°¾Æ,
¼Ò¼Ó »ó¼¼Á¤º¸
À̼®À± ( Lee Suk-Yoon ) - Inje University College of Medicine Inje University Busan Paik Hospital Department of Neurology
¿À¼ºÀÏ ( Oh Seong-Il ) - Inje University College of Medicine Inje University Busan Paik Hospital Department of Neurology
Çã¼Ò¿µ ( Huh So-Young ) - Kosin University College of Medicine Department of Neurology
½Å°æÁø ( Shin Kyong-Jin ) - Inje University Haeundae Paik Hospital Department of Neurology
±èÁ¾±¹ ( Kim Jong-Kuk ) - Dong-A University College of Medicine Peripheral Neuropathy Research Center
À±º°¾Æ ( Yoon Byeol-A ) - Dong-A University College of Medicine Peripheral Neuropathy Research Center

Abstract


Guillain-Barre syndrome (GBS) and Miller Fisher syndrome (MFS) can present with overlapping features. A 56-year-old female developed ptosis and diplopia after an upper respiratory infection, and presented with facial palsy, dysarthria, brachial weakness, ataxia, and areflexia. Mild weakness of both legs appeared after a few days. Anti-ganglioside complex antibody were positive to IgG GM1/GQ1b and GQ1b/sulfatide antibodies. The present case suggests that the manifestation of overlap between MFS/PCB variants and GBS could be caused by antiganglioside complex antibodies.

Ű¿öµå

Guillain-Barre syndrome; Miller Fisher syndrome; Pharyngeal-cervical-brachial variant; Antibodies; Ganglioside; Anti-ganglioside complex

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

µîÀçÀú³Î Á¤º¸